期刊文献+

膀胱癌与人乳头状瘤病毒16/18型感染的相关性研究 被引量:1

Correlation between human papillomavirus 16/18 infections and bladder cancer
原文传递
导出
摘要 目的探讨膀胱移行细胞癌与人乳头状瘤病毒(HPV)16/18型感染的关系,为探索膀胱癌新的治疗预防方案提供科学依据。方法采用第二代杂交捕获技术(HC-Ⅱ)对65例膀胱移行细胞癌组织和30例正常膀胱组织进行HPV感染检测,分析高危HPV16/18感染与膀胱移行细胞癌的关系。结果 65例膀胱癌组织中高危型HPV 16/18检测阳性有42例,阳性率为64.6%,30例正常膀胱组织中高危型HPV16/18检测阳性有2例,阳性率为6.7%;膀胱癌组织中高危型HPV16/18检测阳性率明显高于正常膀胱组织(P<0.05);T2-T4、G3、淋巴结转移组高危型HPV16/18检测阳性率分别明显低于Tis-T1、G1-G2和淋巴结未转移组(P<0.05)。结论 HPV16/18感染可能参与了膀胱移行细胞癌的发病,并对膀胱癌的恶性程度与疾病的进展有一定程度的影响。 OBJECTIVE To investigate the relationship between the human papillomavirus 16/18 infections and the bladder cancer so as to provide scientific basis for exploring the prevention and treatment programs for the bladder cancer. METHODS The second generation hybrid capture technology (HC- Ⅱ ) was used for the detection of HPVs infections in 65 bladder cancer patients and 30 participants with normal bladder tissues ,and the correlation between the high-risk HPV16/18 infections between the bladder cancer was analyzed. RESULTS The positive rate of high risk HPV16/18 infections was 64. 6% (42 cases)in 65 bladder cancer patients and was 6. 7% (2 cases)in 30 participants with normal bladder tissues, the positive rate of the high risk HPV16/18 infections was significantly higher in the patients with bladder cancer than in the participants with normal bladder tissues (P^0.05). The positive rate of the high risk HPV16/18 infections was significantly lower in the patients with metastasis of lymph node, T2-T4 or G3 than in the participants without metastasis of Tis-T1, G1-G2, or lymph node. CONCLUSION The HPV 16/18 infection may involve in the pathogenesis of the bladder cancer and has certain impact on the malignancy and progress of the bladder cancer.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第10期2282-2283,2301,共3页 Chinese Journal of Nosocomiology
关键词 膀胱肿瘤 人乳头状瘤病毒 第二代杂交捕获技术 Bladder neoplasm Human papilloma virus Second generation hybridization capture Ⅱ
  • 相关文献

参考文献7

  • 1Liu C,Wu X,Luo C,et al.Antisense oligonucleotide targe-ting Livin induces apoptosis of human bladder cancer cell via amechanism involving caspase-3[J].J Exp Clin Cancer Res,2010,29(11):63.
  • 2Smith SC,Theodoresu D.The ral GTPase pathway in meta-static bladder cancer:Key mediator and the rapeutiu target[J].Urol Oncol,2009,27(1):42.
  • 3孙志辉,岳天孚.人乳头瘤病毒16/18型与宫颈癌[J].国际妇产科学杂志,2010,37(2):119-121. 被引量:6
  • 4Berlin Grace VM.HPV type 18is more oncopotent than HPV16in uterine cervical carcinogenesis although HPV16is the prevalenttype in Chennm[J].Indian J Cancer,2009,46(3):203-207.
  • 5张培影,徐侠,杨海燕,杨静,王旭波.HPV16/18型表达和细胞病理学检查与宫颈癌及癌前病变的相关性研究[J].南京中医药大学学报,2009,25(1):27-30. 被引量:15
  • 6Castro TM,Bussoloti Filho I,Nascimento VX,et al.HPVdetection in the oral and genital mucosa of women with posi-tive histopathological exam for genital HPV,by means of thePCR[J].Braz J Otorhinolaryngol,2009,75(2):167-171.
  • 7Constandinou-Williams C,Collins SI,Roberts S,et al.Is hu-man papillomavirus viral load a clinically useful predictivemarker:a longitudinal study[J].Cancer Epidemiol Biomark-ers Prey,2010,19(3):832837.

二级参考文献33

  • 1郭建新,李力.HPV与宫颈癌疫苗研究进展[J].国外医学(妇幼保健分册),2004,15(6):395-398. 被引量:9
  • 2钱德英,岑坚敏,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37. 被引量:168
  • 3司马妮,王薇,徐茜,田训,罗爱月,卢运萍,王世宣,马丁.人乳头瘤病毒16型E6、E7反义RNA对人宫颈癌SiHa细胞的恶性逆转作用[J].癌症,2007,26(1):26-31. 被引量:21
  • 4肖静,黄健.对高危型HPV治疗的研究进展[J].现代预防医学,2007,34(8):1464-1465. 被引量:15
  • 5Dehn D,Torkko KC,Shroyer KR.Human papillomavirus testing and molecularmarkers of cervical dysplasia and carcinoma[J].Cancer,2007,111(1):1-14.
  • 6Steben M,Duarte-Franco E.Human papillomavirus infection:epidemiology and pathophysiology[J].Gynecol Oncol,2007,107(2):2-5.
  • 7Seung HS,Jaek L,Oye SS.The relationship between cytokines and HPV 216,HPV 216 E6,E7 and highrisk HPV viralload in the uterine cervix[J].Gynecol Oncol,2007,104(3):732-738.
  • 8Renaud S,Loukinov D,Abdullaer Z,et al.Dual role of DNA methy-lation inside and outside of CTCF2 binding regions in the transcrip-tional regulation of tbe telomerase hTERT gene[J].Nuc Acids Res,2007,35(4):1245-1256.
  • 9Bulk S,Berkhof J,Bulkmans NW,et al.Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Nether-lands[J].Br J Cancer,2006,94(1):171-175.
  • 10Berlin Grace VM.HPV type 18 is more oneopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalenttype in Chennai[J].Indian J Cancer,2009,46(3):203-207.

共引文献18

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部